Riskpilot← Back to searchSign inGet full accessHB GENETICS AKTIEBOLAG
ABActiveOrg 5566151048Solvägen 12Support activities for animal production · NACE 0162Est. 20014 employees
Revenue 2025
SEK 29M
+15% vs 2024
EBITDA margin
23.9%
+20% vs 2024
Equity ratio
74.4%
Financial strength
Net profit 2025
SEK 5,4M
0% vs 2024
| Revenue | SEK 29M | +15% |
| EBITDA | SEK 6,9M | +20% |
| Net profit | SEK 5,4M | +0% |
| Total assets | SEK 27,5M | +28% |
| Equity | SEK 20,5M | +28% |
| Employees | 4 | — |
Legal name
HB GENETICS AKTIEBOLAG
Org number
5566151048
Legal form
Aktiebolag
NACE code
0162 · Support activities for animal production
Founded
6 september 2001
Share capital
SEK 100 000
Employees
4 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Aktiebolaget ska bedriva import och försäljning av tjursperma, embryon samt övriga lantbruksförnödenheter, värdepappersförvaltning, fastighetsförvaltning och därmed förenlig verksamhet.
Address
Solvägen 12
Email
info@hbgenetics.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 19 072 | 20 819 | 24 273 | 25 302 | 29 040 |
| Staff expenses | — | — | — | — | −3 088 |
| EBITDA | 4 101 | 5 594 | 6 374 | 5 798 | 6 948 |
| Depreciation & amort. | −222 | −164 | −243 | −415 | −437 |
| EBIT | 3 879 | 5 430 | 6 131 | 5 383 | 6 510 |
| Net financials | 77 | −56 | 310 | 403 | 247 |
| Profit before tax | 3 937 | 5 349 | 5 982 | 6 830 | 6 826 |
| Tax | −850 | −1 120 | −1 237 | −1 431 | −1 410 |
| Net profit | 3 087 | 4 229 | 4 745 | 5 399 | 5 416 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 27 981 | 31 518 | 36 371 | 21 469 | 27 520 |
| Equity | 23 504 | 26 838 | 30 659 | 16 057 | 20 473 |
| Long-term debt | 0 | 0 | 0 | 0 | — |
| Short-term debt | 3 090 | 3 243 | 3 817 | 4 560 | 6 263 |
| Total debt | 3 090 | 3 243 | 3 817 | 4 560 | 6 263 |
EBITDA margin
23.9%
This company
15.8%
Market median
+51% vs market
20212025
Equity ratio
74.4%
This company
38.2%
Market median
+95% vs market
20212025
Return on equity
26.5%
This company
18.4%
Market median
+44% vs market
20212025
Net profit margin
18.6%
This company
8.1%
Market median
+130% vs market
20212025
Asset turnover
1.06×
This company
1.12×
Market median
+5% vs market
20212025
Debt / equity
0.34×
This company
0.62×
Market median
+45% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
BH | Audit | 2022 |
| Former (2) | ||
SL | Audit | 2020 – 2022 |
AL Auditor Substitute | Auditor Substitute | 2020 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2020 | |
| Deputy Board Member | 2020 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of HB GENETICS AKTIEBOLAG also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Staffan Lennart Jansson | Audit | 0 companies |
| Anders Lennart Karlsson | Auditor Substitute | 0 companies |
| Bengt Hans Peter Karlsson | Audit | 0 companies |
| Hans Magnusson | Board of Directors | 0 companies |
| Brita Christina Magnusson | Deputy Board Member | 0 companies |